Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study

Authors: Augustine Ankomah, John Kuumuori Ganle, Margaret Yaa Lartey, Awewura Kwara, Priscilla Awo Nortey, Michael Perry Kweku Okyerefo, Amos Kankponang Laar

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Timely and enduring access to antiretroviral therapy (ART) by HIV-infected individuals has been shown to substantially reduce HIV transmission risk, HIV-related morbidity and mortality. However, there is evidence that in addition to limited supply of antiretrovirals (ARVs) and linkage to ART in many low-income countries, HIV+ persons often encounter barriers in accessing ART-related services even in contexts where these services are freely available. In Ghana, limited research evidence exists regarding the barriers HIV+ persons already linked to ART face. This paper explores ART access–related barriers that HIV+ persons linked to care in southern Ghana face.

Methods

A mixed method study design, involving a cross-sectional survey and qualitative in-depth interviews, was conducted to collect data from four healthcare providers and a total of 540 adult HIV+ persons receiving ART at four treatment centres in Ghana. We used univariate analysis to generate descriptive tabulations for key variables from the survey. Data from qualitative in-depth interviews were thematically analysed. Results from the survey and in-depth interviews were brought together to illuminate the challenges of the HIV+ persons.

Results

All (100%) the HIV+ persons interviewed were ARV-exposed and linked to ART. Reasons for taking ARVs ranged from beliefs that they will suppress the HIV virus, desire to maintain good health and prolong life, and desire to prevent infection in unborn children, desire both to avoid death and to become good therapeutic citizens (abide by doctors’ advice). Despite this, more than half of the study participants (63.3%) reported seven major factors as barriers hindering access to ART. These were high financial costs associated with accessing and receiving ART (26%), delays associated with receiving care from treatment centres (24%), shortage of drugs and other commodities (23%), stigma (8.8%), fear of side effects of taking ARVs (7.9%), job insecurity arising from regular leave of absence to receive ART (5.3%), and long distance to treatment centres (4.9%).

Conclusions

The results in this study suggest that efforts to provide and scale-up ART to all HIV+ persons must be accompanied by interventions that address structural and individual level access barriers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Keiser O, Anastos K, Schechter M. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Med Int Health. 2008;13:870–9.CrossRef Keiser O, Anastos K, Schechter M. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Tropical Med Int Health. 2008;13:870–9.CrossRef
2.
go back to reference Messeri P, Lee G, Abramson D, Aidala A, Chiasson M, Jessop D. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41(4):512–21.PubMed Messeri P, Lee G, Abramson D, Aidala A, Chiasson M, Jessop D. Antiretroviral therapy and declining AIDS mortality in New York City. Med Care. 2003;41(4):512–21.PubMed
3.
go back to reference van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS. 2003;17(15):2227–36.CrossRefPubMed van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS. 2003;17(15):2227–36.CrossRefPubMed
4.
go back to reference Addo-Atuah J, Gourley D, Gourley G, White-Means IS, Womeodu JR, Faris JR, Addo AN. Accessibility of antiretroviral therapy in Ghana: Convenience of access. SAHARA-J. 2012;9(2):74–87.CrossRefPubMed Addo-Atuah J, Gourley D, Gourley G, White-Means IS, Womeodu JR, Faris JR, Addo AN. Accessibility of antiretroviral therapy in Ghana: Convenience of access. SAHARA-J. 2012;9(2):74–87.CrossRefPubMed
5.
go back to reference Mutevedzi PC, Newell M. The changing face of the HIV epidemic in sub-Saharan Africa. Trop Med Int Health. 2014;19(9):1015–28.CrossRefPubMed Mutevedzi PC, Newell M. The changing face of the HIV epidemic in sub-Saharan Africa. Trop Med Int Health. 2014;19(9):1015–28.CrossRefPubMed
6.
go back to reference UNAIDS. Access to antiretroviral therapy in Africa: status report on progress towards the 2015 targets. Geneva, Switzerland: UNAIDS; 2015. UNAIDS. Access to antiretroviral therapy in Africa: status report on progress towards the 2015 targets. Geneva, Switzerland: UNAIDS; 2015.
7.
go back to reference Kouanda S, Bocoum FY, Doulougou B, Bila B, Yaméogo M, Sanou MJ, Sawadogo M, Sondo B, Msellati P, Desclaux A. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country. AIDS Care. 2010;22(9):1146–52.CrossRefPubMed Kouanda S, Bocoum FY, Doulougou B, Bila B, Yaméogo M, Sanou MJ, Sawadogo M, Sondo B, Msellati P, Desclaux A. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country. AIDS Care. 2010;22(9):1146–52.CrossRefPubMed
8.
go back to reference Barnhart M, Shelton JD. ARVs: the next generation. Going boldly together to new frontiers of HIV treatment. Global Health Sci Pract. 2015;3(1):1–11.CrossRef Barnhart M, Shelton JD. ARVs: the next generation. Going boldly together to new frontiers of HIV treatment. Global Health Sci Pract. 2015;3(1):1–11.CrossRef
9.
10.
go back to reference Ghana Health service. National AIDS/STI Control Programme Ghana Annual Report 2007. Accra: Ghana Health Service; 2007. Ghana Health service. National AIDS/STI Control Programme Ghana Annual Report 2007. Accra: Ghana Health Service; 2007.
11.
go back to reference Ampofo KW. Editorial commentary: Current status of HIV/AIDS treatment, care and support services in Ghana. Ghana Med J. 2009;43(4):142–3.PubMedPubMedCentral Ampofo KW. Editorial commentary: Current status of HIV/AIDS treatment, care and support services in Ghana. Ghana Med J. 2009;43(4):142–3.PubMedPubMedCentral
12.
go back to reference Rasschaert F, van Leemput L, Assefa Y, Schouten E, van Damme W. Tackling health workforce shortages during antiretroviral treatment scale-up—experiences from Ethiopia and Malawi. JAIDS. 2011;57:S109–12.PubMed Rasschaert F, van Leemput L, Assefa Y, Schouten E, van Damme W. Tackling health workforce shortages during antiretroviral treatment scale-up—experiences from Ethiopia and Malawi. JAIDS. 2011;57:S109–12.PubMed
13.
go back to reference Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in Sub‐Saharan Africa. Tropical Med Int Health. 2010;15(s1):70–5.CrossRef Harries AD, Zachariah R, Lawn SD, Rosen S. Strategies to improve patient retention on antiretroviral therapy in Sub‐Saharan Africa. Tropical Med Int Health. 2010;15(s1):70–5.CrossRef
14.
go back to reference Seeling S, Mavhunga F, Thomas A, Adelberger B, Ulrichs T. Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia. Int J Microbiol. 2014;3:268–75. Seeling S, Mavhunga F, Thomas A, Adelberger B, Ulrichs T. Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia. Int J Microbiol. 2014;3:268–75.
15.
go back to reference Denison JA, Koole O, Tsui S, Menten J, Torpey K, van Praag E, Bangsberg DR. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS. 2015;29(3):361–71.CrossRefPubMedPubMedCentral Denison JA, Koole O, Tsui S, Menten J, Torpey K, van Praag E, Bangsberg DR. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia. AIDS. 2015;29(3):361–71.CrossRefPubMedPubMedCentral
16.
go back to reference Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to Pediatric HIV Care and Treatment in South Africa. J Infect Dis. 2007;196 Suppl 3:474–81.CrossRef Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to Pediatric HIV Care and Treatment in South Africa. J Infect Dis. 2007;196 Suppl 3:474–81.CrossRef
17.
go back to reference Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMed Rao D, Kekwaletswe TC, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMed
18.
go back to reference Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19(5):658–65.CrossRefPubMed
19.
go back to reference Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44(11):990–7.CrossRefPubMed Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44(11):990–7.CrossRefPubMed
20.
go back to reference Max B, Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000;30(Supplement 2):S96–S116.CrossRefPubMed Max B, Sherer R. Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis. 2000;30(Supplement 2):S96–S116.CrossRefPubMed
21.
go back to reference Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.CrossRefPubMedPubMedCentral Sayles JN, Wong MD, Kinsler JJ, Martins D, Cunningham WE. The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS. J Gen Intern Med. 2009;24(10):1101–8.CrossRefPubMedPubMedCentral
22.
23.
go back to reference de Waal A, Whiteside A. New variant famine: AIDS and food crisis in southern Africa. Lancet. 2003;362:1234–7.CrossRefPubMed de Waal A, Whiteside A. New variant famine: AIDS and food crisis in southern Africa. Lancet. 2003;362:1234–7.CrossRefPubMed
24.
go back to reference Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, van Cott T, Quinn TC, Rakai Project Team. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.CrossRefPubMed Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, van Cott T, Quinn TC, Rakai Project Team. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.CrossRefPubMed
25.
go back to reference Jewkes R. HIV and women. In: Rohleder P, Swartz L, Kalichman SC, Simbayi LC, editors. HIV/AIDS in South Africa 25 years on: Psychosocial perspectives. New York: Springe; 2009. p. 27–40.CrossRef Jewkes R. HIV and women. In: Rohleder P, Swartz L, Kalichman SC, Simbayi LC, editors. HIV/AIDS in South Africa 25 years on: Psychosocial perspectives. New York: Springe; 2009. p. 27–40.CrossRef
26.
go back to reference Oppong JR, Agyei-Mensah S. HIV/AIDS in West Africa: The case of Senegal, Ghana, and Nigeria. In: Kalipeni E, Craddock S, Oppong JR, Ghosh J, editors. HIV/AIDS in Africa: Beyond epidemiology. Oxford, UK: Blackwell; 2004. p. 70–82. Oppong JR, Agyei-Mensah S. HIV/AIDS in West Africa: The case of Senegal, Ghana, and Nigeria. In: Kalipeni E, Craddock S, Oppong JR, Ghosh J, editors. HIV/AIDS in Africa: Beyond epidemiology. Oxford, UK: Blackwell; 2004. p. 70–82.
27.
go back to reference Yawson A, Appiah KL, Yawson OA, Bonsu G, Aluze-Ele S, Amanhyia NAKO, Lartey M, Adjei AA, Lawson LA, Beckwitt C, Kwara A, Flanigan T. Sex differences in perceived risk and testing experience of HIV in an urban fishing setting in Ghana. Int J Equity Health. 2014;13:109.CrossRefPubMedPubMedCentral Yawson A, Appiah KL, Yawson OA, Bonsu G, Aluze-Ele S, Amanhyia NAKO, Lartey M, Adjei AA, Lawson LA, Beckwitt C, Kwara A, Flanigan T. Sex differences in perceived risk and testing experience of HIV in an urban fishing setting in Ghana. Int J Equity Health. 2014;13:109.CrossRefPubMedPubMedCentral
28.
go back to reference Lindegger G, Quayle M. Masculinities and HIV/ AIDS. In: Rohleder P, Swartz L, Kalichman SC, Simbayi LC, editors. HIV/AIDS in South Africa 25 years on: Psychosocial perspectives. New York: Springe; 2009. p. 41–54.CrossRef Lindegger G, Quayle M. Masculinities and HIV/ AIDS. In: Rohleder P, Swartz L, Kalichman SC, Simbayi LC, editors. HIV/AIDS in South Africa 25 years on: Psychosocial perspectives. New York: Springe; 2009. p. 41–54.CrossRef
29.
go back to reference Skovdal M, Campbell C, Madanhire C, Mupambirey Z, Nyamukapa C, Gregson S. Masculinity as a barrier to men’s use of HIV services in Zambia. Glob Health. 2011;7:1–14.CrossRef Skovdal M, Campbell C, Madanhire C, Mupambirey Z, Nyamukapa C, Gregson S. Masculinity as a barrier to men’s use of HIV services in Zambia. Glob Health. 2011;7:1–14.CrossRef
30.
go back to reference Thielman NM, Ostermann J, Whetten K, Whetten R, Itemba D, Maro V, CHAT Research Team. Reduced adherence to antiretroviral therapy among HIV-Infected Tanzanians seeking cure from the Loliondo Healer. JAIDS. 2014;65(3):e104–9.PubMedPubMedCentral Thielman NM, Ostermann J, Whetten K, Whetten R, Itemba D, Maro V, CHAT Research Team. Reduced adherence to antiretroviral therapy among HIV-Infected Tanzanians seeking cure from the Loliondo Healer. JAIDS. 2014;65(3):e104–9.PubMedPubMedCentral
31.
go back to reference DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207.CrossRefPubMed DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207.CrossRefPubMed
32.
go back to reference Reiter GS, Stewart KE, Wojtusik L, Hewitt R, Segal-Maurer, Johnson M, Fisher A, Zackin R, Masters III H, Bangsberg D. Elements of success in HIV clinical care: Multiple Interventions that promote adherence. Top HIV Med. 2003;8(5):21–30. Reiter GS, Stewart KE, Wojtusik L, Hewitt R, Segal-Maurer, Johnson M, Fisher A, Zackin R, Masters III H, Bangsberg D. Elements of success in HIV clinical care: Multiple Interventions that promote adherence. Top HIV Med. 2003;8(5):21–30.
Metadata
Title
ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study
Authors
Augustine Ankomah
John Kuumuori Ganle
Margaret Yaa Lartey
Awewura Kwara
Priscilla Awo Nortey
Michael Perry Kweku Okyerefo
Amos Kankponang Laar
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2075-0

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.